中国全科医学 ›› 2021, Vol. 24 ›› Issue (2): 205-209.DOI: 10.12114/j.issn.1007-9572.2020.00.486

• 专题研究 • 上一篇    下一篇

骨肽注射液疑似过敏反应影响因素分析:基于7家医疗机构的真实数据

冉超,周虎,谭超,谈军涛,赵文龙*   

  1. 400016重庆市,重庆医科大学医学信息学院
    *通信作者:赵文龙,教授;E-mail:cqzhaowl@163.com
  • 出版日期:2021-01-15 发布日期:2021-01-15
  • 基金资助:
    重庆市社会事业与民生保障科技创新专项(CSTC2015shmszx10004)

Analysis of Influencing Factors of Suspected Allergic Reaction to Ossotide Injection:Based on Real Data from 7 Medical Institutions 

RAN Chao,ZHOU Hu,TAN Chao,TAN Juntao,ZHAO Wenlong*   

  1. School of Medical Informatics of Chongqing Medical University,Chongqing 400016,China
    *Corresponding author:ZHAO Wenlong,Professor;E-mail:cqzhaowl@163.com
  • Published:2021-01-15 Online:2021-01-15

摘要: 背景 国家药品不良反应监测中心监测数据显示应用骨肽注射液可致严重过敏反应,院内发生药物过敏反应可延长患者住院时间,增加患者经济负担,甚至威胁患者生命,但是目前关于骨肽注射液过敏反应影响因素的研究较少。目的 探讨骨肽注射液疑似过敏反应的影响因素,为临床合理用药提供参考。方法 收集7家三甲综合医院2010年1月—2020年1月有骨肽注射液使用记录的住院病历,共计9 351份。采用处方序列分析筛选骨肽注射液疑似过敏反应患者和非过敏患者,将疑似过敏患者纳入疑似过敏组(n=68),采用倾向评分匹配从非过敏患者中按1∶4比例匹配对照组(n=272)。收集两组患者的年龄、性别、住院科室、过敏史及用药情况〔包括骨肽注射液单次给药剂量、溶媒、联合用药(由于样本量的限制选择以骨肽注射液联合用药频数的前20种药品作为分析对象,其中对同一患者的同一种药品用药只取1次记录)〕。采用单因素和多因素Logistic 回归分析骨肽注射液疑似过敏反应的影响因素。结果 单因素Logistic回归分析结果显示,联合用药中氯化钾、奥美拉唑、氨溴索、醋酸钙可能是骨肽注射液疑似过敏反应的影响因素(P<0.05)。多因素Logistic回归分析结果显示,氯化钾(OR=3.515,P=0.003)、奥美拉唑(OR=2.901,P=0.005)、鹿瓜多肽(OR=2.693,P=0.014)是骨肽注射液疑似过敏反应的影响因素。结论 骨肽注射液与奥美拉唑、氯化钾和鹿瓜多肽3种药物联用可增加患者发生疑似过敏反应的风险,但所得分析结果有待进一步的前瞻性研究验证。

关键词: 骨疾病, 骨肽注射液, 过敏反应, 处方序列分析, 病例对照研究, 倾向评分匹配, 影响因素分析

Abstract: Background  The monitoring data of the National Drug Adverse Reaction Monitoring Center showed that the application of ossotide injection can cause severe allergic reaction,and the occurrence of drug allergic reaction in hospital can prolong the time of hospitalizati,increase the financial burden of patients,and even threaten patients' lives.However,there are few studies on the affecting factors of allergic reaction to ossotide injection.Objective To investigate the influencing factors of suspected allergic reactions to ossotide injection,and to provide a reference for clinical rational drug use.Methods The 9 351 cases of inpatient medical records with ossotide injection which were covered by seven 3A general hospitals from January 2010 to January 2020 were collected.The patients with suspected allergic reaction and non-allergic patients were analysised and screened by prescription sequence analysis,and the patients with suspected allergic reaction were included into the group of suspected allergic reaction(n=68).Propensity score matching was used to match the control group from non-allergic patients in a ratio of 1∶4(n=272).The age,sex,hospital department,allergy history and medication use of the two groups were collected〔including single dose of ossotide injection,menstruum and combination medication use(the first 20 drugs of ossotide injection combined drug use frequency were selected for analysis due to the limitation of sample size,and only one drug use was recorded for the same patient)〕.Univariate Logistic regression analysis and multivariate Logistic regression analysis were used to analyze the affecting factors of suspected allergic reaction of ossotide injection.Results Univariate Logistic regression analysis showed that potassium chloride,omeprazole,ambroxol and calcium acetate in the combination of drugs might be the affecting factors of the suspected allergic reaction (P<0.05).Multiple Logistic regression analysis showed that potassium chloride(OR=3.515,P=0.003),omeprazole(OR=2.901,P=0.005),cervus and cucumis polypeptide(OR=2.693,P=0.014) were the influencing factors of suspected allergic reaction to ossotide injection.Conclusion The combination with omeprazole,potassium chloride,and cervus and cucumis polypeptide may increase the risk of allergic reactions in ossotide injection.However,the analysis results need to be verified by further prospective studies.

Key words: Bone diseases, Ossotide injection, Anaphylaxis, Prescription sequence analysis, Case-control studies, Propensity value matching, Root cause analysis